Confidential IPV Screening Tool

Violence, Domestic Clinical Trial

Official title:

EHR-based Screening and Intervention for Intimate Partner Violence

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT06284148
• Other study ID #: Pro00093964
• Secondary ID: 5R18HS025654-03
• Status: Completed
• Phase: N/A
• Start date: October 6, 2010
• Est. completion date: July 31, 2023

Study information

• Verified date: February 2024
• Source: Medical University of South Carolina
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Intimate partner violence (IPV) against women in the US is a serious public health problem and a human rights issue. Our research team has developed confidential screening tools using exam-room computer for intimate partner violence to be used in primary care.

Description:

The objective of this study was to develop and evaluate an integrated suite of electronic health record (EHR) tools that automates "best practices" from Northern California Kaiser Permanente for screening and intervention for IPV identified within clinical settings. The goal of the intervention goes beyond mere screening of patients for IPV and includes tools for assessment of IPV risk, for documentation of IPV care, and support for a warm hand-off during the primary care visit to a national IPV hotline resource. Importantly, the study includes work to keep notes documenting IPV and billing for IPV care confidential, segmenting this care in a secure segment of the electronic health record.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 19655
• Est. completion date: July 31, 2023
• Est. primary completion date: July 31, 2023
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 49 Years

Eligibility

Inclusion Criteria:

• Being an Medical University of South Carolina patient at primary care clinics (family medicine)

• Women 18-49 years of age inclusive

• Reported yes to wanting to be contacted for a follow-up research study

• English-speaking

Exclusion Criteria:

• No exclusion criteria

Related Conditions & MeSH terms

• Violence, Domestic

Intervention

Diagnostic Test:
• Screening for intimate partner violence
confidential screening using exam computer

Other:
• Assessment and referral
confidential assessment and referral of high-risk patients using decision-support templates

Locations

Country	Name	City	State
United States	Biomedical Informatics Center	Charleston	South Carolina

Sponsors (2)

Lead Sponsor	Collaborator
Medical University of South Carolina	Agency for Healthcare Research and Quality (AHRQ)

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	IPV positive (Yes/No)	Depending on patient's answers to screening questions, they are flagged as either IPV positive or negative	29 months
Primary	Screening completed (Yes/No)	Whether the assigned screening was completed during patient visit	29 months
Secondary	Severity of risk	using Danger 5 risk assessment, ranging from 0 to 5	29 months
Secondary	Physician compliance with IPV management tools	Measured as the rate of completion of follow-up decision templates, and the rate of referrals for post-visit counseling to a national hotline (a share from screened positive patients	29 months